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Abstract The 1H nuclear magnetic resonance spectroscopy
was applied to study the reaction of the dipeptide glycyl-D,
L-methionine (H-Gly-D,L-Met-OH) and its N-acetylated
derivative (Ac-Gly-D,L-Met-OH) with hydrogen tetrachlor-
idoaurate(III) (H[AuCl4]). The corresponding peptide and
[AuCl4]
– were reacted in 1:1, 2:1, and 3:1 molar ratios, and
all reactions were performed at pD 2.45 in 0.01 M DCl as
solvent and at 25°C. It was found that the first step of these
reactions is coordination of Au(III) to the thioether sulfur
atom with formation of the gold(III)-peptide complex
[AuCl3(R-Gly-Met-OH-S)] (R=H or Ac). This intermediate
gold(III) complex further reacts with an additional methi-
onine residue to generate the R-Gly-Met-OH chlorosulfo-
nium cation as the second intermediate product, which
readily undergoes hydrolysis to give the corresponding
sulfoxide. The oxidation of the methionine residue in the
reaction between H-Gly-D,L-Met-OH and [AuCl4]
– was five
times faster (k2=0.363±0.074 M
-1s-1) in comparison to the
same process with N-acetylated derivative of this peptide
(k2=0.074±0.007 M
-1s-1). The difference in the oxidation
rates between these two peptides can be attributed to the
free terminal amino group of H-Gly-D,L-Met-OH dipeptide.
The mechanism of this redox process is discussed and, for
its clarification, the reaction of the H-Gly-D,L-Met-OH
dipeptide with [AuCl4]
– was additionally investigated by
UV-Vis and cyclic voltammetry techniques. From these
measurements, it was shown that the [AuCl2]
– complex
under these experimental conditions has a strong tendency
to disproportionate, forming [AuCl4]
– and metallic gold.
This study contributes to a better understanding of the
mechanism of the Au(III)-induced oxidation of methionine
and methionine-containing peptides in relation to the severe
toxicity of anti-arthritic and anticancer gold-based drugs.
Keywords Glycyl-D,L-methionine . Gold(III)-induced
oxidation . 1H NMR . UV-Vis . Cyclic voltammetry .
Gold-based drugs
Introduction
The clinical use of gold compounds, chrysotherapy, is an
accepted part of modern medicine [1–4]. Injectible gold(I)
thiolates, such as sodium aurothiomalate, aurothioglucose,
and aurothiopropanol sulfonate, and the oral drug auranofin
are used clinically against rheumatoid arthritis [1–4]. A
large number of gold(I) compounds have also been tested
for antitumor activity against various cancerous cell lines
[5–9]. A wide variety of phosphinegold(I) thiolates display
significant cytotoxicity in vitro [10, 11]. Gold(III) com-
plexes, isostructural and isoelectronic with platinum(II),
have also been evaluated as potential candidates for cancer
treatment. In comparison to Pt(II) complexes, Au(III)
analogs are relatively unstable, light-sensitive [12], and
easily reducible, which makes them less effective [13] and
probably more toxic as metal-based drugs. However, in
recent years, new gold(III) compounds were synthesized,
characterized, and shown to have appreciable stability
under physiological conditions [14]. In order to enhance
the stability of the gold(III) center, polydentate ligands,
such as polyamines, cyclam, terpyridine, phenanthroline,
and dithiocarbamates, were used [13–16]. Some of these
gold(III) complexes displayed in vitro cytotoxicity compa-
rable or even higher than cisplatin toward several human
tumor cell lines resistant to cisplatin [11, 16–22].
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The clinical application of gold complexes is limited
because of severe toxicity such as blood disorders and
kidney damage [23]. It was suggested that Au(III) produced
from Au(I) drugs might be responsible for the toxic side
effects encountered in chrysotherapy [20, 23–25]. Strong
oxidants, which can oxidize Au(I) to Au(III), are potentially
available in vivo in inflammatory situations [26, 27]. Anti-
arthritic gold(I) drugs can be oxidized to Au(III) by the
hypochlorite ion generated from H2O2 and Cl
– in the
presence of the enzyme myeloperoxidase, which is pro-
duced and released by phagocytic cells [27]. Au(III) is very
short-lived in the presence of different biomolecules
because it can rapidly oxidize them, thereby being reduced
to Au(I). It has been known for some time that Au(III) can
oxidize thiols to disulfides [28, 29], cleave the disulfide
bond of cystine to give the sulfonic acid [28–31], oxidize
dialkyl sulfides to sulfoxide [32], the sulfur atom of the
amino acid methionine stereospecifically to methionine-
sulfoxide [33–37], and can desulfonate thioamides [38].
The structural consequences of these reactions can play an
important role in the toxic side effects of gold-based drugs.
Previous kinetics studies of the reaction between
[AuCl4]
– and amino acid L-methionine provide evidence
that this reaction occurred in two stages [34, 35]. Very fast
substitution of one chloride ion in [AuCl4]
– complex by a
methionine molecule was followed by slow reduction of
this intermediate Au(III)–methionine complex with forma-
tion of the methionine-sulfoxide and Au(I) species as the
final products of this reaction. Although the oxidation of
amino acid methionine by Au(III) ion has been extensively
investigated, the mechanism of the redox process is not yet
completely understood. In order to gain more information
on the mechanism of methionine oxidation with gold(III)
ion in the present study, special attention was paid to the
identification of intermediate and final products for the
reactions of glycyl-D,L-methionine dipeptide and its N-





glycyl-D,L-methionine (H-Gly-D,L-Met-OH), and deuterium
oxide (99.8 %) were obtained from the Sigma-Aldrich
Chemical Co. Hydrochloric acid and potassium chloride
were obtained from Zorka Pharma, Šabac. All the employed
chemicals were of analytical reagent grade, and doubly
distilled water was used throughout. The terminal amino
group in the H-Gly-D,L-Met-OH dipeptide was acetylated by
a standard method [39].
1H NMR spectroscopy
All the 1H nuclear magnetic resonance (NMR) spectra were
recorded on a Varian Gemini 2000 spectrometer (200 MHz)
using 5-mm NMR tubes. Sodium trimethylsilylpropane-3-
sulfonate (TSP) was used as an internal reference. The 1H
NMR spectra were acquired using the WATERGATE
sequence for water suppression. Typical acquisition con-
ditions were as follows, 90° pulses, 24,000 data number
points, 4 s acquisition time, 1 s relaxation delay, collection
of 16–128 transients, and final digital resolution of 0.18 Hz
per point. All the NMR spectra were processed using the
Varian VNMR software (version 6.1, revision C). The
chemical shifts are reported in parts per million (ppm).
The NMR samples were prepared in 0.01 M DCl in D2O
as solvent, and the total volume was 600 μl. Fresh solutions
of dipeptide and H[AuCl4]
.3H2O were prepared separately
and then mixed in different molar ratios (1:1, 2:1, and 3:1)
at room temperature. The initial concentration of H[AuCl4]
was 20 mM. All rate constants were obtained from 1H
NMR measurements. The values of the rate constants for
the reactions between equimolar amounts of [AuCl4]
– and
R-Gly-D,L-Met-OH dipeptide (R=H or Ac) were determined
when the data from the reactions were fitted to a second-
order process [40] by plotting x/ao(ao–x) against t (where ao
is the initial concentration of the R-Gly-D,L-Met-OH
dipeptide and x is the concentration of the corresponding
sulfoxide at time t).
UV-Vis spectrophotometry
The ultraviolet-visible (UV-Vis) spectra were recorded on a
Perkin Elmer Lambda 35 double-beam spectrophotometer
equipped with thermostated 1.00-cm quartz Suprasil cells.
Stock solutions of H[AuCl4]
.3H2O and dipeptide were
prepared directly before use in 0.01 M HCl (pH 2.00). H-
Gly-D,L-Met-OH and H[AuCl4] were mixed in 1:1, 2:1, and
3:1 molar ratios, respectively, at room temperature, with the
concentration of H[AuCl4] in the final solution being 5×
10–5 M. The kinetic measurements were made by repeti-
tively scanning the spectra at set time intervals over the
wavelength range 200–500 nm. Data were collected and
analyzed using Origin 6.1 and Microsoft Office Excel 2003
programs.
Voltammetric measurements by cyclic voltammetry
Cyclic voltammetric (CV) measurements were performed
with an Autolab potentiostat (PGSTAT 302 N). The
working electrode for the cyclic voltammetric measure-
ments was glassy carbon (GC) with 3 mm inner and
9 mm outer diameter of the PTFE sleeve. Prior to use,
the GC electrode was wet-polished on an Alpha A
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polishing cloth (Mark V Lab) with successively smaller
particles (0.3- and 0.05-μm diameter) of alumina. The
electrode was washed twice with doubly distilled water
and then with the background electrolyte solution. The
washed electrode was then placed into a voltammetric
cell with supporting electrolyte solution. The reference
electrode was a saturated calomel electrode type 401
(Radiometer, Copenhagen), and the counter electrode was
a platinum wire.
Stock solutions of H[AuCl4]
.3H2O and the dipeptide were
prepared just before use by dissolving H[AuCl4]
.3H2O and
H-Gly-D,L-Met-OH in 0.01 M HCl, which were then diluted
with 0.01 M HCl to give the working solutions. The required
amount of the dipeptide and H[AuCl4] were mixed in
different molar ratios (1:1, 2:1, and 3:1, respectively) with
the final concentration of H[AuCl4] being 1.05 mM. The
supporting electrolyte used to perform the cyclic voltam-
metric experiments was 0.04 M NaCl at pH 2.00. The time
interval between two consecutive voltammograms was 30 s.
The measurements were realized in the background electro-
lyte (pH 2.00) at a scan rate of 0.070 Vs–1. The conditions
were the following, Ebegin=0.0 V, Eend=1.5 V, and Estep=
0.003 V. All experiments were performed at room temper-
ature and repeated at least three times. The data were
collected and analyzed using the Origin 6.1 program.
pH measurements
All pH measurements were made at room temperature. The
pH meter (Iskra MA 5704) was calibrated with a Fischer-
certified buffer solution of pH 4.00. Reported pD values
were corrected for the deuterium isotopic effect by adding
0.45 units to the pH meter reading [41].
Results and discussion
The reactions between H-Gly-D,L-Met-OH or Ac-Gly-D,
L-Met-OH, and [AuCl4]
– were studied by 1H NMR
spectroscopy, and in addition of this study, the reaction of
H-Gly-D,L-Met-OH with [AuCl4]
– was investigated by UV-
Vis and CV techniques. All reactions were performed at pD
2.45 in 0.01 M DCl (or pH 2.00 in 0.01 M HCl) as solvent
and at 25°C. Differences in the reactivity between these two
dipeptides were compared in order to investigate the
influence of the terminal amino group of glycine on the
rate of oxidation of the methionine residue. All reactions
were carried out in different molar ratios (peptide, gold(III)=
1:1, 2:1, and 3:1, respectively), and for each case, the reaction
mixture was kept at pH 2.00 in order to suppress, or minimize,
hydrolysis of [AuCl4]
– anion that was reported to be
completed at pH 3.80 [42]. However, in our case, hydrolytic
products of [AuCl4]
– followed by very fast reduction of gold
(III) to Au(0) appeared at pH≥3.00.
The reaction of [AuCl4]
– with an equimolar amounts
of H-Gly-D,L-Met-OH and Ac-Gly-D,L-Met-OH dipeptides
When an equimolar amount of H[AuCl4]
.3H2O was
incubated with the corresponding R-Gly-D,L-Met-OH di-
peptide (R=H or Ac) under the above-mentioned condi-
tions, three NMR detectable products were observed in
solution in the first 3 min of the reaction (Fig. 1). The time
dependence of the formation of the products in this reaction
is shown in Fig. 2. The major product obtained in a yield of
52% was H-Gly-Met-OH sulfoxide and 47% for Ac-Gly-
Met-OH sulfoxide (product 3; Fig. 1), formed by the
oxidation of the corresponding dipeptides with [AuCl4]
–.
The resonance at 2.71 ppm was assigned to the methyl
protons of product 3, which is in agreement with those
previously reported for [H-Gly-Met-OH sulfoxide]+[AuCl4]
–
characterized by 1H NMR spectroscopy and X-ray
crystallography [37].
The other two products 1 and 2 in Fig. 1, observed in the
first 3 min of the reaction, were intermediate species.
Product 1 resulted from the coordination of Au(III) to the
thioether sulfur with formation of the gold(III)–peptide
complex [AuCl3(R-Gly-Met-OH-S)]. This intermediate
gold(III) complex further reacts with an additional methi-
onine residue to generate Au(I) complex and intermediate
species 2 which readily undergoes hydrolysis yielding to
the corresponding sulfoxide 3 as the final product in this
investigated reaction. The reaction pathway for the present
investigation reaction (see Fig. 1) is thus similar to that
pH = 2.00;








































R = H or CH3CO (Ac)
Fig. 1 Schematic presentation of the oxidation reaction of H-Gly-D,L-Met-OH and Ac-Gly-D,L-Met-OH in the presence of H[AuCl4]
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operative in the oxidation of organic sulfides with bromine,
resulting in the corresponding sulfoxides [43, 44]. Further-
more, the same reaction mechanism was suggested by
Natile et al. in the kinetic study of the reduction gold(III) to
gold(I) by dialkyl sulfides in aqueous methanol solution
[32]. The formations of products 1 and 2 are evident in the
1H NMR spectrum from the chemical shifts of the
resonances at 2.89 and 2.79 ppm, due to the methyl protons
of the methionine residue (Fig. 2a, b). The signal at
2.89 ppm belongs to the product 1 while the upfield shifted
signal at 2.79 ppm was assigned to the –SCH3 protons of
product 2. The concentration of each intermediate product
was calculated from the integral values of these two signals
and during the first 3 min of the reaction these products
were obtained in a yield of 28% (or 30%) for 1 and 20% (or
23%) for product 2 for H-Gly-D,L-Met-OH and Ac-Gly-D,
L-Met-OH, respectively. The total amount of products 1 and
2 and the final product 3 was always equal to the initial
concentration of the dipeptide. The intensities of the signals
at 2.79 and 2.89 ppm decreased during time with their
complete disappearance after the subsequent 9 min for H-
Gly-D,L-Met-OH and 57 min for Ac-Gly-D,L-Met-OH
(Fig. 2a, b). During this time, the intensity of the signal at
2.71 ppm for the methyl protons of product 3 was
enhanced, and finally, its concentration was equal to the
initial concentration of the corresponding dipeptide.
From above proton NMR results, it can be concluded
that at the stoichiometric amounts of the reactants, the
oxidation of the methionine residue in H-Gly-D,L-Met-OH
to its sulfoxide was five times faster (k2=0.363±0.074 M
-1s-1)
in comparison to the same process between the N-
acetylated derivative of this peptide and [AuCl4]
– (k2=
0.074±0.007 M-1s-1). The difference in the oxidation rates
between these two peptides can be attributed to the free
terminal amino group of H-Gly-D,L-Met-OH dipeptide.
These results are in accordance with those previously
reported for the reaction of L-methionine with [AuCl4]
–,
where it was stated that the NH2 group was involved in the
oxidation of this amino acid to its sulfoxide [34, 35].
The reaction of H-Gly-D,L-Met-OH with H[AuCl4]
.3H2O
was studied by UV-Vis spectrophotometric measurements
in 0.01 M HCl as solvent (pH 2.00) at 25°C; see Fig. 3. As
it can be seen from this figure, when an equimolar amount
of the peptide was added to a solution of [AuCl4]
–, the
Fig. 2 Parts of the 1H NMR
spectra during the reaction of
H-Gly-D,L-Met-OH (a) and
Ac-Gly-D,L-Met-OH (b) with an
equimolar amount of H[AuCl4]
as a function of time at pD 2.45
and at 25°C in 0.01 M DCl in
D2O as solvent with TSP as the
internal standard. The
resonances at 2.89, 2.79, and
2.71 ppm are assigned for the
S–CH3 protons of the products
1, 2, and 3, respectively
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absorbance of two maxima at 1=226 and 1=313 nm
decreased during 12 min of the reaction, which indicates a
decreasing [AuCl4]
– concentration. After this time, no
change in the absorbance was observed, indicating that this
redox process was finished. The total amount of [AuCl4]
–
consumed during this redox reaction was calculated from
differences in absorbance of the maximum at 1=226 nm
before addition of the peptide and after 12 min of the
reaction. It was found that approximately 33% of [AuCl4]
–
remained in solution after completion of this redox reaction.
Due to the fact that the oxidation of methionine residue in
the presence of gold(III) was undoubtedly confirmed as a
stoichiometric reaction [34, 35], obviously, the excess of
[AuCl4]
– resulted from the disproportionation of [AuCl2]
–
to Au(0) and [AuCl4]
–. The disproportionation of the
aqueous Au(I) complex was extensively investigated in
literature, and the following reaction for decomposition of
this complex was proposed: 3[AuCl2]
– ↔ 2Au(0) +
[AuCl4]
– + 2Cl– [45, 46]. It was found that the rate of this
reaction at room temperature was very slow in the early
stage of the reaction and then rapidly increased to values
that remained approximately constant with further reaction
progress (log K=7.4 at 25°C) [46, 47]. Furthermore, recent
crystallographic results for [H-Gly-Met-OH sulfoxi-
de]+[AuCl4]
– obtained by oxidation of the corresponding
peptide in the presence of an equimolar amount of [AuCl4]
–
additionally confirmed that disproportionation of [AuCl2]
–
occurred under these circumstances [37].
The above 1H NMR and UV-Vis results for the reaction
of H-Gly-D,L-Met-OH with [AuCl4]
– revealed good agree-
ment with those obtained for CV measurements. The
survey cyclic voltammogram (Fig. 4a) of a 1.05 mM
solution of H[AuCl4] in 0.01 M HCl in the presence of
0.04 M NaCl as background electrolyte recorded at a GC
electrode displayed a distinct cathodic peak I at 0.32 V:
AuCl4 þ 3e ! Au0þ 4Cl [48]. The Au(III)–Au(0) re-
duction was also evident from the presence of metallic gold
on the electrode surface. In the cyclic voltammogram, no
[AuCl2]
– complex could be detected due to the fact that the
chlorido ligand is not a π-acceptor which could stabilize
this complex [48]. On the reverse sweep, a definite
oxidation wave I′ at 1.02 V was observed (Fig. 4a):
Au0þ 4Cl ! AuCl4 þ 3e .
As a result of the formation of product 1 (see Fig. 1) in
the reaction between equimolar amounts of H-Gly-D,L-Met-
OH and H[AuCl4], the characteristic peak I′ was shifted
from 1.02 to 0.85 V (peak II′, Fig. 4a). Furthermore, as a
consequence of the progress of this reaction, the current
response decreased with time in relation to characteristic























Fig. 4 a Cyclic voltammograms of H[AuCl4] (solid line) and product
1 (dashed line) recorded in the first 30 s of the reaction; b Survey
cyclic voltammograms recorded during the progress of the reaction
between equimolar amounts of H-Gly-D,L-Met-OH and H[AuCl4] of a
GC electrode, scan rate=0.070 Vs–1, Estep=0.003 V, pH 2.00, and
40 mM NaCl as background electrolyte. The vertical arrows indicate











Fig. 3 UV-Vis spectra recorded during the reaction of H[AuCl4] with
an equimolar amount of H-Gly-D,L-Met-OH at pH 2.00 and at 25°C in
0.01 M HCl as solvent (1:0; 2:30; 3:60; 4:180; 5:720 s of reaction)
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anodic peak II′, while the characteristic cathodic peak II
increased (at 0.35 V; Fig. 4b). The current enhancement of
the cathodic peak is purely dependent on the degree of
reduction of Au(III) to Au(0). As can be also seen from
Fig. 4b, the reaction was finished after 12 min. This is
coupled with the fact that, after 12 min, there was no
change of the current response of the characteristic anodic
peak as well as the characteristic cathodic peak.
The reaction of [AuCl4]
– with an excess
of H-Gly-D,L-Met-OH and Ac-Gly-D,L-Met-OH dipeptides
The oxidation of the methionine residue in the presence of
[AuCl4]
– was studied in an excess of the H-Gly-D,L-Met-
OH or the Ac-Gly-D,L-Met-OH dipeptide. The [AuCl4]
– and
the corresponding peptide were mixed in 1:2 or 1:3 molar
ratio, respectively, and all reactions were performed under
the above-mentioned experimental conditions. The first 1H
NMR spectrum ran in the first 3 min of reaction indicated
that the oxidation of the methionine residue was almost
over. The absence of resonances in the 1H NMR spectrum
at 2.89 and 2.79 ppm due to the methyl protons of the
intermediate products 1 and 2, respectively, (see Fig. 1)
indicates that the redox process with an excess of the H-
Gly-D,L-Met-OH or Ac-Gly-D,L-Met-OH dipeptide was
much faster than with equimolar amounts of [AuCl4]
– and
dipeptide. The amount of product 3 was calculated from the
intensity of the signal at 2.71 ppm in respect to the initial
concentration of the dipeptide, and the total amount of this
product was approximately 50% for the 1:2 and 33% for the
1:3 molar ratio for each sulfoxide. The singlets at 2.50 ppm
for H-Gly-D,L-Met-OH and at 2.56 ppm for Ac-Gly-D,
L-Met-OH were assigned to the methyl protons of these
two dipeptides both coordinated to Au(I) through the
methionine sulfur atom. These chemical shifts are consis-
tent with those previously reported for polynuclear Au(I)–
sulfur-type complexes [49]. When the reaction of [AuCl4]
–
with H-Gly-D,L-Met-OH was followed during time, the
signal at 2.50 ppm shifted to a higher field, from 2.50 to
2.11 ppm. It can be assumed that this shifting was caused
by the replacement of H-Gly-D,L-Met-OH in the polynu-
clear {[Au(H-Gly-Met-OH-S)2]}n complex with chloride
ion, resulting after 6 h in the formation of free dipeptide
(signal at 2.11 ppm). These results are in accordance with
those previously reported of the relatively strong affinity
of Au(I) for sulfur-containing ligands, such as thiols,
thiolates, and sulfides, and also of the lability of Au(I)–
sulfur bound species in solution [50]. However, in the
reaction between Ac-Gly-D,L-Met-OH and [AuCl4]
– under
the above-mentioned conditions, the chemical shifts of the
resonance at 2.56 ppm due to the methyl protons of the
polynuclear {[Au(Ac-Gly-Met-OH-S)2]}n complex did not
change during 6 days of reaction. The consistent value for
the chemical shifts of these protons can be explained by
the higher stability of the polynuclear {[Au(Ac-Gly-Met-
OH-S)2]}n complex with respect to that obtained in the
reaction of the non-acetylated dipeptide with a free
terminal amino group. These results are in accordance
with those previously reported by Sadler et al. [36] that the
stability of Au(I)-methionine species is dependent on the
availability of free NH2 groups, which catalyze their
disproportionation.


















Fig. 5 Cyclic voltammograms
of product 1 recorded in the first
30 s of the reaction between
H[AuCl4] and H-Gly-D,L-Met-OH
in 1:1 (solid line), 1:2 (dotted
line), and 1:3 (dashed line) molar
ratios, respectively. The inserted
figure shows the dependence of
the peak current of the character-
istic anodic peak of product 1 in
relation to increasing
concentrations of peptide
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The reaction of [AuCl4]
– with excess of H-Gly-D,L-Met-
OH was also investigated under the above-mentioned
experimental conditions by UV-Vis and CV measurements.
Very fast change in absorbance of [AuCl4]
– with no
presence of this anion in the UV-Vis spectrum was
observed at the end of these reactions. These findings are
in accordance to the fact that the color of the solution had
finally changed from yellow to colorless. Also, the current
response of the anodic peak also decreased rapidly under
these circumstances (see Fig. 5).
Concluding remarks
From the present investigation of the reactions of H[AuCl4]
with H-Gly-D,L-Met-OH and its N-acetyl derivative Ac-
Gly-D,L-Met-OH, at pD 2.45 in 0.01 M DCl (or pH 2.00 in
0.01 M HCl) and at 25°C, the following conclusions can be
drawn. The gold(III)-induced oxidation of the methionine
residue in these peptides to the corresponding sulfoxides
proceeded in two steps. The first step of this reaction is
very fast coordination of Au(III) to the thioether sulfur with
formation of the gold(III)–peptide complex [AuCl3(R-Gly-
Met-OH-S)] (R=H or Ac). This gold(III) complex further
reacts with an additional methionine residue to generate the
R-Gly-Met-OH chlorosulfonium cation as the second interme-
diate product, which readily undergoes hydrolysis to give the
corresponding sulfoxide. The [AuCl2]
– complex formed in the
reaction with equimolar amounts of reactants showed a strong
tendency to disproportionate to [AuCl4]
– and metallic gold as
the final products of this redox process. However, in the
presence of excess of the dipeptide, the resulting polynuclear
H-Gly-D,L-Met-S-Au(I) and Ac-Gly-D,L-Met-S-Au(I) com-
plexes showed themselves to be quite stable products. The
finding that the oxidation of the methionine residue in Ac-
Gly-D,L-Met-OH to its sulfoxide was five times slower than
that in the non-protected H-Gly-D,L-Met-OH dipeptide
undoubtedly confirmed that the terminal amino group of the
methionine-containing peptide had an evident influence on
the acceleration of this redox process.
The results from this study together with those obtained
in previous studies [33–37] show that gold(III)-induced
oxidation of methionine, methionine-containing peptides,
and proteins may be important in relation to the severe
toxicity of gold-based drugs. Based on the above-
mentioned hypotheses, studies aimed at investigating the
interactions of gold(III) complexes with sulfur-containing
peptides can be of great importance for the medical
application of gold-based drugs.
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